Coronavirus: Emergency planning for the drug supply chain

The FDA has outlined its expectations and actions regarding supply chain and inspections in China

picture of

Breaking News

DuPont enters microbiome therapy collaboration with MRM Health

MRM has raised more than $15m to advance its clinical and preclinical development programmes

The Native Antigen Company introduces novel coronavirus antigen

UK company has developed rapid response manufacturing capabilities to produce reagents for emerging epidemic diseases

CNS Pharmaceuticals completes FDA reprocessing stipulations for API

US-based biotech has completed pilot manufacturing steps persuant to FDA pre-IND guidance for production of API for new ...

The Lonza powder-in-capsule microdosing approach

Jeff Williamson and Ben Sahacic explain how microdosing offers a proven approach for biopharmaceutical companies to ...

Uni teams develop new hydrogel-based fermentation production method

Texas and Washington University teams have developed a new way to produce molecules on demand and preserve them using ...

Novo Nordisk plans $117m API manufacturing expansion

Danish company’s Kalundborg headquarters that manufactures insulin API will be expanded by 2022

John Baker: Life sciences need to address the reproducibility crisis

The head of product innovation at Abcam says it is crucial that the whole industry finds ways to de-risk the route to ...

Indena receives Gates Foundation grant to optimise antimalarials

The Gates Foundation has funded a strategic project to improve two new potential antimalarial synthetic drug therapies ...

GE Healthcare collaborates to develop ligands for AAV purification

Australian Children’s Medical Research Institute and GE have agreed to develop new affinity ligands for the ...

UK medical cannabis: Quality under scrutiny

Andrew James, Marketing Director of Ellutia, explains how chromatography can uncover the potency of a batch of cannabis ...

IntelGenx: Oral films are drug development’s patent trick

Exploiting improvements in bioavailability, the Canadian company has developed unique oral film technology to help ...

Managing the unavoidable: A practical approach to handling TUPs

Technically unavoidable particles (TUPs) are found in chemical raw materials, such as excipients. They do not pose a ...

Avacta, Daewoong and AffyXell to work on proteins for a range of targets

AffyCell has agreed to provide funds to Avacta for R&D costs of proteins produced by mesenchymal stem cells

CPI evaluates NADH recycling tech from Oxford University

The Centre for Process Innovation has worked with Oxford Uni to scale up beads with immobilised enzymes that recycle ...